Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
Metrics | Range | Conclusion |
---|---|---|
Selected LTM Pb Multiple | 16.0x - 17.6x | 16.8x |
Historical Pb Multiple | 0.0x - 11.4x | 5.6x |
Fair Value | €0.098 - €0.11 | €0.10 |
Upside | -46.2% - -40.6% | -43.4% |
Benchmarks | - | Full Ticker |
Arch Biopartners Inc. | - | TSXV:ARCH |
Innovotech Inc. | - | TSXV:IOT |
Sona Nanotech Inc. | - | CNSX:SONA |
ImmunoPrecise Antibodies Ltd. | - | NasdaqCM:IPA |
AbCellera Biologics Inc. | - | NasdaqGS:ABCL |
Telescope Innovations Corp. | - | DB:J4U |
Select Price / Book Ratio | ||||||||
Benchmark Companies | ||||||||
ARCH | IOT | SONA | IPA | ABCL | J4U | |||
TSXV:ARCH | TSXV:IOT | CNSX:SONA | NasdaqCM:IPA | NasdaqGS:ABCL | DB:J4U | |||
Historical Net Income Growth | ||||||||
5Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
3Y CAGR | NM- | -15.1% | NM- | NM- | NM- | NM- | ||
Latest Twelve Months | -41.7% | 321.8% | 6.3% | -242.9% | -14.3% | -161.6% | ||
Historical Net Income Profit Margin | ||||||||
5 Year Average Margin | -2318.7% | 1.0% | NA | -85.0% | -150.2% | -161.3% | ||
Prior Fiscal Year | -167.7% | -13.3% | NA | -128.5% | -385.0% | -25.4% | ||
Latest Fiscal Year | -184.8% | 10.2% | NA | -110.8% | -564.8% | -29.9% | ||
Latest Twelve Months | 1247.7% | 12.9% | NA | -194.8% | -726.3% | -46.2% | ||
Return on Equity | ||||||||
5 Year Average Margin | NA | 6.8% | -902.5% | -39.8% | 7.1% | -394.4% | ||
Prior Fiscal Year | NM | -15.9% | -430.2% | -39.9% | -12.3% | -33.8% | ||
Latest Twelve Months | NM | 22.6% | -390.5% | -124.7% | -15.6% | -138.6% | ||
Next Fiscal Year | 114.3% | -20.2% | -671.8% | -31.2% | -19.0% | #NUM! | ||
Two Fiscal Years Forward | 53.3% | 19.0% | 147.7% | -18.9% | -25.4% | -481.7% | ||
Current Trading Multiples | ||||||||
Price / LTM Sales | -482.0x | 4.4x | NA | 2.7x | 47.5x | 3.9x | ||
Price / LTM EPS | -38.6x | 34.3x | -19.9x | -1.4x | -6.5x | -8.4x | ||
Price / Book | -31.1x | 5.1x | 57.8x | 2.6x | 1.1x | 32.4x | ||
Price / Fwd Book | -7.4x | 6.4x | -43.1x | 2.7x | 1.2x | 10.4x | ||
Low | Mid | High | ||||||
Benchmark P/B Ratio | -31.1x | 2.6x | 57.8x | |||||
Historical P/B Ratio | 0.0x | 5.6x | 11.4x | |||||
Selected P/B Multiple | 16.0x | 16.8x | 17.6x | |||||
(x) Book Value | 1 | 1 | 1 |
Equity Value | |||||||
Benchmark Companies | |||||||
(in millions) | ARCH | IOT | SONA | IPA | ABCL | J4U | |
Value of Common Equity | 119 | 13 | 59 | 68 | 1,042 | 16 | |
(/) Shares Outstanding | 65.9 | 49.9 | 112.5 | 45.8 | 298.5 | 53.7 | |
Implied Stock Price | 1.80 | 0.27 | 0.52 | 1.48 | 3.49 | 0.29 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.36 | 1.00 | 1.61 | |
Implied Stock Price (Trading Cur) | 1.80 | 0.27 | 0.52 | 1.09 | 3.49 | 0.18 | |
Trading Currency | CAD | CAD | CAD | USD | USD | EUR | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.36 | 1.00 | 1.61 |